Bill Kirkland, CEO; Collexis Holdings Inc., headquartered in Capitol Place (aka AT&T Building), announced July 10 its enterprise license agreement and ongoing engagement with the National Institutes of Health (NIH), the largest funder of health sciences research in the world. Over $20 billion a year in federal grant funding will now be analyzed by the Collexis platform.

Collexis Holdings Inc., a global knowledge discovery company since 1999, has two subsidiaries, Collexis Inc. in Columbia and Collexis, B.V. in Geldermalsen, The Netherlands. Collexis patented technology builds conceptual profiles of text, called fingerprints, from documents, Websites, e- mails, and other digitized content to create applications to search, index, and aggregate information as well as categorize and predict data based on sources in multiple fields - all without the limitations of language or dialect.

The company's mission is to develop software supporting knowledge retrieval and discovery across multiple industries.

Collexis shares of common stock are traded under the symbol CLXS on the over- the- counter bulletin board. For a Yahoo Finance review of the stock's recent past, place CLXS.OB in the search window.

director; Collexis opened its first day on the stock market at $3 on Monday, July 2, and hit $11.50 on Thursday, July 5. On Tuesday, July 10, Collexis shares were trading at $10.50.

The NIH agreement also enables all their related research institutions to utilize the Collexis software for categorization, search, expertise identification, discovery, and analysis of text- based content. Content examples include publications, grants, patents, and other scientific works and information.

"We're very excited about our relationship with the NIH and are confident Collexis will be a valuable asset to its 27 institutions. The Collexis analysis of grant content fits with the NIH's roadmap toward a digital future in research. Our software will help increase efficiency, consistency, and transparency as it pertains to the NIH's needs," said Bill Kirkland, CEO, Collexis Holdings, Inc.

Leicht, vice president sales of Collexis Holdings, Inc. The arrangement represents an important milestone for Collexis and adds another elite, first- mover institution to the ranks of those who have adopted Collexis's research software, including Johns Hopkins University, Harvard University, Morehouse School of Medicine, University of California (San Francisco), University of South Carolina, Bristol- Myers Squibb, Merck & Co. Inc., Lockheed Martin, the World Health Organization, Wellcome Trust, and others.

"With the addition of NIH and Wellcome Trust, Collexis has become the grants categorization, management, and reporting standard for the largest public and largest private health science research funders in the world," said Steve Leicht, Collexis vice president of sales. "The NIH has their pick of the best technology. We are gratified that NIH has used its expertise, time, and talent to do the necessary examination and comparison and has selected Collexis as its provider of text analysis software. Clearly, Collexis is at the leading edge of the marketplace," Leicht added.